NLRP3 and inflammatory bowel disease: THP-1 cells were incubated with LPS, a well-recognized activator of the first step of NLRP3 signaling as well as a hallmark of altered intestinal permeability, a condition typically observed in the murine model of colitis and IBD patients [42, 43].